Envestnet Asset Management Inc Neogenomics Inc Transaction History
Envestnet Asset Management Inc
- $299 Billion
- Q1 2025
A detailed history of Envestnet Asset Management Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 64,068 shares of NEO stock, worth $468,337. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,068
Previous 80,902
20.81%
Holding current value
$468,337
Previous $1.33 Million
54.39%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$144 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$104 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$49.1 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$44.2 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$42 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $920M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...